Skip to content
Disclosery

EXANE DERIVATIVES: AAP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AAP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,433 AAP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,433 shares
    Change vs previous 13F -1,271 shares

    0.34% of the 13F portfolio, value $594,097.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,704 shares
    Change vs previous 13F -97 shares

    0.27% of the 13F portfolio, value $973,480.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,801 shares
    Change vs previous 13F +4,796 shares

    0.28% of the 13F portfolio, value $1,151,622.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 5 shares
    Change vs previous 13F -2,399 shares

    <0.01% of the 13F portfolio, value $1,044.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,404 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $502,352.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).